Search

Your search keyword '"Filipits, M."' showing total 386 results

Search Constraints

Start Over You searched for: Author "Filipits, M." Remove constraint Author: "Filipits, M."
386 results on '"Filipits, M."'

Search Results

4. ERRα promotes breast cancer cell dissemination to bone by increasing RANK expression in primary breast tumors

6. 123O Randomized phase II trial of neoadjuvant atezolizumab in combination with dual HER2 blockade plus epirubicin in early HER2-positive breast cancer (ABCSG-52/ATHENE)

7. P270 Is the CTS5 a helpful decision-making tool in the extended adjuvant therapy setting?

8. Identifying clinically relevant prognostic subgroups of postmenopausal women with node-positive hormone receptor-positive early-stage breast cancer treated with endocrine therapy: a combined analysis of ABCSG-8 and ATAC using the PAM50 risk of recurrence score and intrinsic subtype

10. Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone

22. Prediction of chemotherapy benefit by EndoPredict in patients with breast cancer who received adjuvant endocrine therapy plus chemotherapy or endocrine therapy alone

26. Association of p27 and cyclin D1 expression and benefit from adjuvant trastuzumab treatment in HER2-positive early breast cancer: A TransHERA study

31. Abstract P2-08-04: Prediction of distant recurrence by EndoPredict in patients with estrogen receptor-positive, HER2-negative breast cancer who received adjuvant endocrine therapy plus chemotherapy (ET+C) or endocrine therapy alone (ET)

32. Abstract P1-17-05: The impact of clinical risk assessment versus PAM-50 ROR score on prognosis and therapeutic decision making in patients with hormone-receptor positive early stage breast cancer

33. Abstract P4-08-05: Prediction of distant recurrence using EndoPredict among women with ER-positive, HER2-negative breast cancer with a maximum follow-up of 16 years

34. Expression of ARs in triple negative breast cancer tumors: a potential prognostic factor?

35. PAM-50 predicts local recurrence after breast cancer surgery in postmenopausal patients with ER1/HER2- disease: results from 1204 patients in the randomized ABCSG-8 trial.

37. ERRα promotes breast cancer cell dissemination to bone by increasing RANK expression in primary breast tumors

38. mRNA expression of ER, PR, HER2 and Ki67 are concordant to central ihc and predict clinical outcome: A validation study from the ABCSG-6 biomarker cohort

39. Abstract GS6-04: The EndoPredict score predicts residual cancer burden after neoadjuvant chemotherapy and after neoendocrince therapy in HR+/HER2- breast cancer patients from ABCSG 34

40. Third CECOG consensus on the systemic treatment of non-small-cell lung cancer

41. P2.09-004 PD-L1 Protein Expression Is Negative Prognostic Factor in Malignant Pleural Mesothelioma in Central Europe

43. Expression of ARs in triple negative breast cancer tumors: A potential prognostic factor?

44. Upregulation of osteoprotegerin expression correlates with bone invasion and predicts poor clinical outcome in oral cancer

48. Abstract P2-08-21: Stromal co-expression of urokinase-type plasminogen activator (uPA) and plasminogen activator Inhibitor (PAI-1) protein by IHC predicts poor disease outcome in endocrine-treated postmenopausal patients with receptor-positive early breast cancer

49. Programmed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastoma

Catalog

Books, media, physical & digital resources